Cost‐effectiveness analysis of dabigatran, rivaroxaban and warfarin in the prevention of stroke in patients with atrial fibrillation in China

Persistence and outcomes of non-vitamin K antagonist oral anticoagulants versus warfarin in patients with non-valvular atrial fibrillation

(2019) Shanshan Wu et al.   JOURNAL OF CLINICAL NURSING

Thromboembolic, bleeding, and mortality risks among patients with nonvalvular atrial fibrillation treated with dual antiplatelet therapy versus oral anticoagulants: A population-based study

(2019) Wallis C.Y. Lau et al.   HEART RHYTHM

Epidemiology of atrial fibrillation

(2018) Hanis Zulkifly et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Epidemiological Characteristics of Atrial Fibrillation in Southern China: Results from the Guangzhou Heart Study

(2018) Hai Deng et al.   Scientific Reports

Decreased risk of renal impairment in atrial fibrillation patients receiving non-vitamin K antagonist oral anticoagulants: A pooled analysis of randomized controlled trials and real-world studies

(2018) Chi Zhang et al.   THROMBOSIS RESEARCH

Real-World Setting Comparison of Nonvitamin-K Antagonist Oral Anticoagulants Versus Vitamin-K Antagonists for Stroke Prevention in Atrial Fibrillation

(2017) George Ntaios et al.   STROKE

Real-World Use of Apixaban for Stroke Prevention in Atrial Fibrillation

(2017) Marco Proietti et al.   STROKE

Efficacy and safety of rivaroxaban versus warfarin in patients from mainland China with nonvalvular atrial fibrillation: A subgroup analysis from the ROCKET AF trial

(2017) Yihong Sun et al.   THROMBOSIS RESEARCH

Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis

(2017) José A López-López et al.   BMJ-British Medical Journal

Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis

(2017) José A López-López et al.   BMJ-British Medical Journal

Efficacy and safety of dabigatran, rivaroxaban, and warfarin for stroke prevention in Chinese patients with atrial fibrillation: the Hong Kong Atrial Fibrillation Project

(2016) Wen-Hua Li et al.   CLINICAL CARDIOLOGY

Cost-Effectiveness Analysis of Apixaban, Dabigatran, Rivaroxaban, and Warfarin for Stroke Prevention in Atrial Fibrillation in Taiwan

(2016) Chieh-Yu Liu et al.   CLINICAL DRUG INVESTIGATION

A randomized controlled trial on rehabilitation through caregiver-delivered nurse-organized service programs for disabled stroke patients in rural china (the RECOVER trial): design and rationale

(2016) Lijing L Yan et al.   International Journal of Stroke

Wytyczne ESC dotyczące leczenia migotania przedsionków w 2016 roku, opracowane we współpracy z EACTS

(2016) Paulus Kirchhof et al.   Kardiologia Polska

Prospective National Study of the Prevalence, Incidence, Management and Outcome of a Large Contemporary Cohort of Patients With Incident Non-Valvular Atrial Fibrillation

(2015) M. Haim et al.   Journal of the American Heart Association

Global epidemiology of atrial fibrillation

(2014) Faisal Rahman et al.   Nature Reviews Cardiology

Stroke prevention in atrial fibrillation: An Asian perspective

(2014) Kang-Ling Wang et al.   THROMBOSIS AND HAEMOSTASIS

Conventional and New Oral Anticoagulants in the Treatment of Chest Disease and Its Complications

(2013) Pilar Gallego et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Worldwide Epidemiology of Atrial Fibrillation

(2013) Sumeet S. Chugh et al.   CIRCULATION

Treatment with novel oral anticoagulants

(2013) Shari Ghanny et al.   CURRENT OPINION IN HEMATOLOGY

Atrial Fibrillation, Stroke Risk, and Warfarin Therapy Revisited

(2013) Staffan Björck et al.   STROKE

Atrial Fibrillation and Anticoagulation Therapy

(2011) David Vivas et al.   CIRCULATION JOURNAL

Cost-Effectiveness of Tissue-Type Plasminogen Activator in the 3- to 4.5-Hour Time Window for Acute Ischemic Stroke

(2011) Christie E. Tung et al.   STROKE

Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach

(2009) Gregory Y.H. Lip et al.   CHEST

Patterns of Hospital Performance in Acute Myocardial Infarction and Heart Failure 30-Day Mortality and Readmission

(2009) Harlan M. Krumholz et al.